MK-677 Research for Body Composition
An evidence-based overview of research examining MK-677 in the context of body composition. This page synthesizes findings from peer-reviewed literature.
Research Summary
Studies show MK-677 increases fat-free mass and may reduce visceral fat. The drug's effects on body composition are mediated through elevated GH and IGF-1. In dietary restriction studies, MK-677 preserved lean body mass compared to placebo. The anti-catabolic effects may be beneficial during weight loss. However, MK-677 can increase appetite (through ghrelin pathway activation) and may cause fluid retention, complicating body composition goals.
Referenced Studies
Click any PMID to view the full study on PubMed.
Other Peptides Studied for Body Composition
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. MK-677 may have regulatory approval for some indications but should only be used under qualified medical supervision. Always consult a healthcare provider before making health decisions.